<DOC>
	<DOCNO>NCT01833286</DOCNO>
	<brief_summary>Hepatocellular carcinoma ( HCC ) fifth common cancer world . Partial hepatectomy still consider conventional therapy HCC . Intrahepatic recurrence HCC partial hepatectomy common report 77 % within 5 year surgery . Repeat hepatectomy effective treatment intrahepatic HCC recurrence , 5-year survival rate 19.4-56 % . This comparable survival initial hepatectomy HCC . Unfortunately , repeat hepatectomy could carry small proportion patient HCC recurrence ( 10.4-31 % ) , either poor functional liver reserve widespread intrahepatic recurrence . In past two decade , percutaneous radiofrequency ablation ( PRFA ) emerge new treatment modality attract great interest effectiveness safety small HCC ( ≤ 5.0 cm ) . Studies use PRFA treat recurrent HCC partial hepatectomy report 3-year survival rate 62-68 % , comparable achieve surgery . PRFA particularly suitable treat recurrent HCC partial hepatectomy tumor usually detect small PRFA cause least deterioration liver function patient . Our previous retrospective study demonstrate RFA comparable re-resection recurrent HCC , recent RCT show RFA combine TACE superior RFA HCC ≤7.0cm . So hypothesis RFA combine TACE superior re-resection recurrent small HCC . The aim retrospective study compare outcome reresection TACE+RFA small recurrent HCC partial hepatectomy .</brief_summary>
	<brief_title>TACE+RFA Versus Re-resection Recurrent Small Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1. age 18 75 year ; 2. recurrence HCC 12 month initial hepatectomy ; 3. treatment receive except initial hepatectomy ; 4 . Single tumor≤5cm diameter ; 23 lesion ≤ 3.0 cm 5. lesion visible ultrasound acceptable safe path lesion skin show ultrasound ; 6. severe coagulation disorder ( prothrombin activity &lt; 40 % platelet count &lt; 40,000 / mm3 ; 7 . Eastern Cooperative Oncology Group performance ( ECOG ) status 0 1 1. presence vascular invasion extrahepatic spread imaging ; 2. ChildPugh class C liver cirrhosis evidence hepatic decompensation include ascites , severe coagulation disorder ( prothrombin activity &lt; 40 % platelet count &lt; 40,000 / mm3 ) , esophageal gastric variceal bleed hepatic encephalopathy ; 3. American Society Anesthesiologists ( ASA ) score ≥ 3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>repeat hepatectomy</keyword>
	<keyword>radiofrequency ablation</keyword>
	<keyword>transcatheter arterial chemoembolization</keyword>
</DOC>